Post-approval studies (Phase 4)Study completedNCT00545233
What this trial is testing
PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.
Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 155